Log in to search using one of your social media accounts:

This page shows you the latest news items in this category.

FDA approves Radius Health's osteoporosis drug Tymlos
(Reuters) - The U.S. Food and Drug Administration on Friday approved Radius Health Inc's drug to treat osteoporosis in postmenopausal women at high risk of fracture or those who have failed other therapies. (Source: Reuters: Health)
Source: Reuters: Health - April 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Clears Abaloparatide for High-Risk Osteoporosis Patients FDA Clears Abaloparatide for High-Risk Osteoporosis Patients
Abaloparatide is the first new anabolic treatment approved for postmenopausal women with osteoporosis in the United States in nearly 15 years.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 28, 2017 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news

FDA Approves Tymlos (abaloparatide) for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture
WALTHAM, Mass., April 28, 2017 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing innovative therapeutics in the areas of osteoporosis, oncology and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 28, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves Radius Health’s TYMLOS(TM) (abaloparatide), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture
TYMLOS is the first new anabolic (bone building) agent for postmenopausal women with osteoporosis in the United States in nearly 15 years US Commercial Launch in May Approval Based on Results at 18 months from the Landmark ACTIVE Trial and the first ... Biopharmaceuticals, FDA Radius Health, TYMLOS, abaloparatide, osteoporosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 28, 2017 Category: Pharmaceuticals Source Type: news

​FDA approves Radius Health osteoporosis drug, but adds cancer warning
The FDA on Friday approved an osteoporosis drug made by Waltham-based Radius Health, but added a so-called "black box" warning that the treatment had increased the risk of bone cancer in rats. Radius (Nasdaq: RDUS) is hoping that abaloparatide, which will be sold under the brand name Tymlos, will eventually take on Forteo, an osteoporosis treatment sold by Eli Lilly (NYSE: LLY) that generated $1.5 billion in sales last year. Forteo has the same warning, which states that the drug increa sed the risk… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 28, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

​FDA approves Radius Health osteoporosis drug, but adds cancer warning
The FDA on Friday approved an osteoporosis drug made by Waltham-based Radius Health, but added a so-called "black box" warning that the treatment had increased the risk of bone cancer in rats. Radius (Nasdaq: RDUS) is hoping that abaloparatide, which will be sold under the brand name Tymlos, will eventually take on Forteo, an osteoporosis treatment sold by Eli Lilly (NYSE: LLY) that generated $1.5 billion in sales last year. Forteo has the same warning, which states that the drug increa sed the risk… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 28, 2017 Category: American Health Authors: Max Stendahl Source Type: news

Osteoporosis Treatment Efficacy for Men Osteoporosis Treatment Efficacy for Men
While osteoporotic fractures are most often studied in women, men are affected as well. Which osteoporosis treatment options offer the best protection for men?Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 28, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Guidelines Issued on Managing Bone Loss Tied to Aromatase Inhibitor Therapy (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM Several professional groups, including the International Osteoporosis Foundation, have issued a position statement on managing bone loss in postmenopausal women receiving adjuvant aromatase inhibitor therapy for breast … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 26, 2017 Category: Primary Care Source Type: news

Women of South Asian descent 'may be at greater risk of osteoporosis'
This study focused on trends in bone resorption, the process by which bone tissue is broken down by osteoclast cells to enable the transfer of calcium from bone tissue into the bloodstream. This is an essential function that help to body adapt to change and repair damage, but when it becomes excessive and unbalanced, it can be detrimental to bone health. Researchers examined 370 pre and postmenopausal South Asian and white Caucasian women in the UK over a 12-month period by measuring levels of N terminal telopeptide, a byproduct of bone resorption found in urine. It was found that premenopausal South Asian women had higher...
Source: Arthritis Research UK - April 26, 2017 Category: Rheumatology Source Type: news

Osteoporosis-Drug Holidays for Low-Risk Patients: EMAS Concurs Osteoporosis-Drug Holidays for Low-Risk Patients: EMAS Concurs
A new EMAS position paper on the appropriate use of a drug holiday following treatment for osteoporosis in patients at low risk for fracture concurs with that of the American Society for Bone and Mineral Research.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 26, 2017 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Bare bones: Making bones transparent
A new bone clearing technique is a breakthrough for testing osteoporosis drugs. The technique has promising applications for understanding how bones interact with the rest of the body. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 26, 2017 Category: Science Source Type: news

Bare bones: Making bones transparent
(California Institute of Technology) A new bone clearing technique is a breakthrough for testing osteoporosis drugs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 26, 2017 Category: Global & Universal Source Type: news

Intense training without proper recovery may compromise bone health in elite rowers
Bone mineral density, an indicator of bone strength, typically increases with regular exercise, acting as a protective mechanism against bone fractures and osteoporosis. But a new study suggests that the extended, high-intensity training sessions of elite athletes could reverse beneficial bone changes. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 25, 2017 Category: Science Source Type: news

Four cups of coffee 'not bad for health' suggests review
Conclusion It appears that previous recommendations from the 2003 Health Canada review into the effects of caffeine on health remain suitable. Health Canada recommended a maximum daily coffee intake of 400mg/day for healthy adults and 300mg/day for pregnant women. Although this review looked at a large number of studies and found that the evidence overall supports these recommendations, there are some limitations to the research: The number of studies providing evidence for each health outcome varied. Some results were based on a large number of studies, others on a much smaller number. This means the strength of evide...
Source: NHS News Feed - April 25, 2017 Category: Consumer Health News Tags: Food/diet Pregnancy/child Source Type: news

Post-fracture care: Do we need to educate patients rather than doctors?
This multicenter, randomized controlled trial involved 436 women, aged 50-85 years, who had attended hospital for treatment of a fragility fracture of the wrist or upper arm. The intervention group received repeated oral and written information about fragility fractures and osteoporosis management by a case manager, who prompted the patients to visit their primary care physicians to ask for BMD testing and management. This was found to improve the rate of post-fracture BMD testing by 20%. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 25, 2017 Category: Science Source Type: news

This Is What Your Teeth Can Reveal About Your Overall Health
The dentist may not be your favorite appointment, but it’s a necessity.  Good oral hygiene saves you from more than just tooth decay, cavities and bad breath. It is critically important because it can help prevent certain medical conditions such as cardiovascular disease and osteoporosis. And here’s something else: The state of your teeth, mouth and gums can clue your dentist into other medical issues you may need to address. By examining your mouth, your dentist can identify eating disorders, sleeping problems, anxiety, stress and more. Below are some of the things dentists can see about yo...
Source: Healthy Living - The Huffington Post - April 25, 2017 Category: Consumer Health News Source Type: news

Effects of balance-coordination, strengthening and aerobic exercises to prevent falls in postmenopausal patients with osteoporosis: a 6-month randomized parallel prospective study - Dizdar M, Irdesel JF, Dizdar OS, Topsac M.
Osteoporosis is a systemic disease characterized by the increase of bone fragility and fracture risk. Postmenopausal female osteoporotic patients were randomized into 3 groups;balance and coordination, strengthening, and aerobic exercise group. The exercis... (Source: SafetyLit)
Source: SafetyLit - April 25, 2017 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Post-fracture care: Do we need to educate patients rather than doctors?
(International Osteoporosis Foundation) This multicenter, randomized controlled trial involved 436 women, aged 50-85 years, who had attended hospital for treatment of a fragility fracture of the wrist or upper arm. The intervention group received repeated oral and written information about fragility fractures and osteoporosis management by a case manager, who prompted the patients to visit their primary care physicians to ask for BMD testing and management. This was found to improve the rate of post-fracture BMD testing by 20%. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 25, 2017 Category: Global & Universal Source Type: news

New guidance for management of aromatase-inhibitor related bone loss in breast cancer
(International Osteoporosis Foundation) Women treated with aromatase-inhibitors (AI) for breast cancer experience a two to four-fold increase in bone loss compared to the normal rate of bone loss with menopause -- and as a result they are at heightened risk of fracture. This new Position Statement, jointly published by seven international and European organizations, identifies fracture-related risk factors in these patients and outlines key management strategies to help prevent bone loss and fractures. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 25, 2017 Category: Global & Universal Source Type: news

UK National Osteoporosis Guideline Group (NOGG) launches 2017 update
The Society for Endocrinology is pleased to announce that the UK National Osteoporosis Guideline Group (NOGG) 2017 Update has now been released via theirwebsite. This new Guideline, accredited by NICE, includes a number of updates on risk assessment, management and treatments. An obvious change is the alteration to the age-related assessment and intervention thresholds so that these now remain constant from the age of 70 years upwards. The thresholds remain automatically accessible from the FRAX UK risk assessment tool. The full Guideline, and an updatedPatient Information Leaflet, are a...
Source: Society for Endocrinology - April 24, 2017 Category: Endocrinology Source Type: news

Ask the expert: What is the female athlete triad and how can it be prevented?
The spring athletics season is in full swing and for those at the high school and college level, practices and game schedules can be intense. When you blend this physical commitment with the demands of a hectic academic schedule, sometimes maintaining healthy eating habits and positive energy balance can be challenging. Dr. Kathryn Ackerman, medical director of Boston Children’s Female Athlete Program, shares important information about a condition called the female athlete triad and offers tools to keep young athletes healthy, energized and at the top of their game. What is the female athlete triad?  The female ...
Source: Thrive, Children's Hospital Boston - April 21, 2017 Category: Pediatrics Authors: Maureen McCarthy Tags: Ask the Expert Female Athlete Program female athlete triad Kathryn Ackerman Source Type: news

Eating clean, unprocessed foods is now a dangerous "cult," declares idiotic mainstream media (with a little help from the dirty diary industry)
(Natural News) As more people are turning their back to dairy and other processed foods, the National Osteoporosis Society, subsidized by the milk industry, has now declared clean eating to be a dangerous “cult” and “ticking time bomb” that could leave young people with weak bones. For decades, the milk industry has made us believe... (Source: NaturalNews.com)
Source: NaturalNews.com - April 21, 2017 Category: Consumer Health News Source Type: news

Reassuring Long-term Safety Trends With Denosumab Treatment Reassuring Long-term Safety Trends With Denosumab Treatment
There appear to be no worsening safety trends when denosumab is used long term for the treatment of osteoporosis in postmenopausal women, according to the seven-year FREEDOM Extension trial.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - April 20, 2017 Category: Orthopaedics Tags: Rheumatology News Source Type: news

Osteoporosis Quiz: What is Osteoporosis?
Title: Osteoporosis Quiz: What is Osteoporosis?Category: MedicineNet QuizCreated: 1/14/2011 12:00:00 AMLast Editorial Review: 4/20/2017 5:56:50 PM (Source: MedicineNet Senior Health General)
Source: MedicineNet Senior Health General - April 20, 2017 Category: Geriatrics Source Type: news

Value of Osteoporosis Drugs Uncertain in Patients With CKD Value of Osteoporosis Drugs Uncertain in Patients With CKD
The benefits and harms of drugs used to treat osteoporosis in patients with chronic kidney disease are still uncertain, according to a systemic review and meta-analysis of the literature.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 18, 2017 Category: Consumer Health News Tags: Orthopaedics News Source Type: news

Periodic check-ups key to baby boomer health and longevity
For somebaby boomers, getting ready for a routine visit with their doctor is like training for a marathon.  Some patients want to be in the best shape possible before stepping on that scale and getting those lab results. Others are so anxious about their vital stats being below par that they consider postponing or even canceling their examinations, doctors report.According to theU.S. Census Bureau, the term “baby boomers” refers to the 71 million people born between 1946 and 1964. The first boomers began hitting age 65 at the rate of 10,000 per day in 2011.Now finding themselves in the age range  between 53 and 71 ...
Source: UCLA Newsroom: Health Sciences - April 15, 2017 Category: Universities & Medical Training Source Type: news

There's A Major Downside To Going Dairy-Free
If you’re drinking almond and coconut milk instead of dairy, listen up. A recent U.K. survey from the National Osteoporosis Society shows that one fifth of young adults are reducing dairy or going dairy-free, possibly because of fad dieting trends and not necessarily because it’s the advice of a doctor. But experts warn that cutting dairy could have potential health consequences. Young people may be slashing crucial nutrients like calcium during a period when their body needs it most. “Diet in early adulthood is so important because by the time we get into our late 20s it is too late t...
Source: Healthy Living - The Huffington Post - April 14, 2017 Category: Consumer Health News Source Type: news

Dairy industry front group declares eating "clean food" promotes disease; tells youth to drink DIRTY MILK for lifelong health
(Natural News) In the latest hilarious example of fake science from a dirty, dishonest industry, the so-called National Osteoporosis Society — little more than a junk science front group for the dirty dairy industry — has declared clean eating to be a “dangerous timebomb.” According to the group, clean food promotes disease, while the best... (Source: NaturalNews.com)
Source: NaturalNews.com - April 13, 2017 Category: Consumer Health News Source Type: news

Adapted combat sports on bone related variables and functional independence of postmenopausal women in pharmacological treatment - Borba-Pinheiro CJ, Dantas EHM, Vale RGS, Drigo AJ, Carvalho MCGA, Tonini T, Meza EIA, Figueiredo NMA.
Background and study Aim: Osteoporosis is a chronic disease that leads to bone fragility and is associated with fracture risks and serious consequences for mobility. The aim of study was effects of adapted judo and karate programs of on bone mineral densit... (Source: SafetyLit)
Source: SafetyLit - April 13, 2017 Category: Global & Universal Tags: Age: Elder Adults Source Type: news

Three million young adults putting their future health in danger
The National Osteoporosis Society (NOS) is warning that the current eating habits of teenagers and young adults is a ticking time bomb for their bones and time is running out for them to prevent permanent damage. (Source: NHS Networks)
Source: NHS Networks - April 13, 2017 Category: UK Health Source Type: news

Uncertain Benefits with Bone Tx in CKD (CME/CE)
(MedPage Today) -- Effects of osteoporosis meds on BMD, fracture risk not clear (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 12, 2017 Category: Endocrinology Source Type: news

Diets lacking in dairy may put health at risk
A new study from the National Osteoporosis Society in England has found some alarming trends in dieting among teenagers and young adults. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 12, 2017 Category: Consumer Health News Source Type: news

Osteoporosis warning as THIS diet plan branded ‘ticking time bomb’
OSTEOPOROSIS is a condition which weakens bones and makes them more likely to break. However experts have warned people who cut certain foods out of their diet could be at risk of causing permanent damage. (Source: Daily Express - Health)
Source: Daily Express - Health - April 12, 2017 Category: Consumer Health News Source Type: news

Clean living diets 'creating a generation with weak bones'
Research by the National Osteoporosis Society found that four in ten 18 to 24 year olds have tried the diets, which often involve cutting out entire food groups including gluten and dairy. (Source: the Mail online | Health)
Source: the Mail online | Health - April 12, 2017 Category: Consumer Health News Source Type: news

Delayed recognition of thoracic and lumbar vertebral compression fractures in minor accident cases - Hatgis J, Granville M, Jacobson RE.
Osteoporotic vertebral compression fractures (VCFs) in the elderly are commonly diagnosed after a minor fall or trauma; however, the majority of these patients have either been previously evaluated for osteoporosis or are already under some form of medical... (Source: SafetyLit)
Source: SafetyLit - April 11, 2017 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Osteoporosis Drugs Have Uncertain Benefit in Chronic Kidney Disease (FREE)
By Joe Elia Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD The benefits of osteoporosis drugs for preserving bone health in patients with chronic kidney disease are uncertain, according to an Annals … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 11, 2017 Category: Primary Care Source Type: news

Why Are So Many People Popping Vitamin D?
There is no epidemic of vitamin D deficiency, experts say, yet pointless testing and treatment are rampant. (Source: NYT Health)
Source: NYT Health - April 10, 2017 Category: Consumer Health News Authors: GINA KOLATA Tags: Vitamins Vitamin D Tests (Medical) Bones Sunlight Osteoporosis Source Type: news

Osteoporosis drug found safe for postmenopausal women in long-term trial
A new clinical trial has shown the short- and long-term safety of the drug denosumab to treat postmenopausal osteoporosis. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 7, 2017 Category: Consumer Health News Source Type: news

Abaloparatide Best in ' Really High-Risk ' Osteoporosis Patients Abaloparatide Best in ' Really High-Risk ' Osteoporosis Patients
As anticipated US approval for a new anabolic agent, abaloparatide, for osteoporosis is delayed by 3 months, one expert discussed how he thinks the agent will best fit into the armamentarium.Medscape Medical News (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - April 6, 2017 Category: Orthopaedics Tags: Diabetes & Endocrinology News Source Type: news

Colorado study finds insomnia may cause osteoporosis
In the latest study by the University of Colorado, men were found to have reduced levels of bone formation after just three weeks of poor sleep. This increased their risk of developing osteoporosis. (Source: the Mail online | Health)
Source: the Mail online | Health - April 3, 2017 Category: Consumer Health News Source Type: news

Amgen And UCB Report New Data At ENDO 2017 Examining The Option Of A Second Course Of Treatment With EVENITY ™ (romosozumab)
THOUSAND OAKS, Calif. and BRUSSELS, April 1, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis. The results were presented in an oral session (OR08-1) at ENDO 2017, the Endocrine Society's Annual Meeting in Orlando, Fla. In the study, postmenopausal women with low bone mass (lumbar spine, total hip or femoral neck T score between -2.0 and -3.5) were initially randomized t...
Source: Amgen News Release - April 1, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Endocrine Society, Medscape partner to bring endocrine expertise to clinicians worldwide
(The Endocrine Society) The Endocrine Society and Medscape announced today a new partnership that brings together the Society's expertise and Medscape's innovative, peer-to-peer digital platforms and award-winning content to provide clinicians with the latest guidance and most relevant insights on diagnosing and treating diabetes, obesity, osteoporosis, infertility, and other endocrine disorders. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 31, 2017 Category: Global & Universal Source Type: news

Estrogen for osteoporosis tied to lower risk of gum infections
(Reuters Health) - - After menopause, women who take estrogen therapy may be less likely to develop severe oral health problems than peers who don ’t take hormones or other treatments for age-related bone damage, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - March 29, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Non-coding RNA molecule could play a role in osteoporosis
A new study inNature Communicationssuggests micro RNA miR-214-3p plays a role in regulating bone formation through increasing osteoclast activity and reducing osteoblast activity.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - March 29, 2017 Category: Endocrinology Source Type: news

Making bones stronger
(University of Delaware) New treatments for osteoporosis are desperately needed. Two University of Delaware scientists report estimates of potentially the most effective dosage of a particular peptide, with results that could raise density levels in badly degraded bones back to healthy levels. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2017 Category: Global & Universal Source Type: news

Breastfeeding 'doesn't boost children's intelligence'
Conclusion This study has tackled the controversial question of whether there are long-term benefits of breastfeeding for cognitive ability or problem behaviours when children are older (ages three to five). Although they found very limited evidence of benefit, the authors do note that there are some other studies that have used a similar analysis but found differing results. The researchers think this could be due to slight differences in analysis. This does highlight the difficulties in being absolutely certain whether breastfeeding has direct impact on long-term cognitive outcomes. What we can say is that, if there ar...
Source: NHS News Feed - March 28, 2017 Category: Consumer Health News Tags: Pregnancy/child Mental health Neurology Source Type: news

IOF President's Award honors global osteoporosis experts and advocates
(International Osteoporosis Foundation) Seven leading osteoporosis experts and advocates have received the 2017 International Osteoporosis Foundation (IOF) President's Award in recognition of their contributions to IOF and their commitment to advancing education and awareness in the field within their regions. The presentations took place on March 24, 2017 during the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in Florence, Italy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 27, 2017 Category: Global & Universal Source Type: news

U.S. Appeals Court Revives Fosamax Warning Claims Against Merck U.S. Appeals Court Revives Fosamax Warning Claims Against Merck
A federal appeals court on Wednesday revived hundreds of claims by plaintiffs who accused Merck& Co of failing to adequately warn about the risks of thigh bone fractures associated with its osteoporosis drug Fosamax (alendronate).Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - March 23, 2017 Category: Orthopaedics Tags: Rheumatology News Source Type: news

Fragile bones and weak muscles take center stage at IOF-ESCEO World Congress in Florence
(International Osteoporosis Foundation) Researchers and clinicians from all regions of the world will be gathering in Florence, Italy today for the opening of the World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO Florence 2017), froml March 23-26, 2017 at the Fortezza da Basso Congress center. The annual Congress is hosted by the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis& Musculoskeletal Diseases (ESCEO). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2017 Category: Global & Universal Source Type: news

Weight-bearing exercises promote bone formation in men
Osteoporosis affects more than 200 million people worldwide and is a serious public health concern, according to research. Now, newly published work is the first in men to show that long-term, weight-bearing exercises decrease sclerostin, a protein made in the bone, and increase IGF-1, a hormone associated with bone growth. These changes promote bone formation, increasing bone density. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 22, 2017 Category: Science Source Type: news